These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2448416)

  • 21. Stability of foot-and-mouth disease virus, its genome and proteins at 37 degrees C.
    Razdan R; Sen AK; Rao BV; Suryanarayana VV
    Acta Virol; 1996 Feb; 40(1):9-14. PubMed ID: 8886092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity.
    Knipe T; Rieder E; Baxt B; Ward G; Mason PW
    J Virol; 1997 Apr; 71(4):2851-6. PubMed ID: 9060641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig.
    Núñez JI; Baranowski E; Molina N; Ruiz-Jarabo CM; Sánchez C; Domingo E; Sobrino F
    J Virol; 2001 Apr; 75(8):3977-83. PubMed ID: 11264387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of foot-and-mouth disease virus vaccine strains by activation of virus-associated endonuclease.
    Scodeller EA; Lebendiker MA; Dubra MS; Crespo OA; Basarab O; La Torre JL; Vasquez C
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1567-73. PubMed ID: 6088682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electron microscopy studies on the proliferation of foot-and-mouth disease virus in cell cultures. II. Changes in nucleic acid metabolism of the cell nucleus].
    Schulze P; Olechnowitz AF
    Arch Exp Veterinarmed; 1975 Jun; 29(3):427-39. PubMed ID: 172042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sedimentation characteristics of virion RNA of Machupo virus reproducing in the presence of actinomycin D].
    Golubev VP; Scheslenok EP; Finskaia NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1985 Jun; (6):37-40. PubMed ID: 3025713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a foot-and-mouth disease polyuridylic acid polymerase and its inhibition by antibody.
    Polatnick J
    J Virol; 1980 Feb; 33(2):774-9. PubMed ID: 6251248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus.
    Rosas MF; Vieira YA; Postigo R; Martín-Acebes MA; Armas-Portela R; Martínez-Salas E; Sobrino F
    Virology; 2008 Oct; 380(1):34-45. PubMed ID: 18694581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
    Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N
    Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG.
    Gutiérrez A; Rodríguez A; Pintado B; Sobrino F
    Antiviral Res; 1993 Sep; 22(1):1-13. PubMed ID: 8250540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid cell variation can determine the establishment of a persistent viral infection.
    Martín Hernández AM; Carrillo EC; Sevilla N; Domingo E
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3705-9. PubMed ID: 8170973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex.
    Newman JF; Brown F
    J Virol; 1997 Oct; 71(10):7657-62. PubMed ID: 9311848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
    J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the secondary structure of the poly(C) tract in foot-and-mouth disease virus RNAs.
    Mellor EJ; Brown F; Harris TJ
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1919-29. PubMed ID: 2993483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifications of the 5' untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture.
    Escarmís C; Toja M; Medina M; Domingo E
    Virus Res; 1992 Nov; 26(2):113-25. PubMed ID: 1335672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic lesions associated with Muller's ratchet in an RNA virus.
    Escarmís C; Dávila M; Charpentier N; Bracho A; Moya A; Domingo E
    J Mol Biol; 1996 Nov; 264(2):255-67. PubMed ID: 8951375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.
    Mason PW; Baxt B; Brown F; Harber J; Murdin A; Wimmer E
    Virology; 1993 Feb; 192(2):568-77. PubMed ID: 8380665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication.
    Sáiz M; Gómez S; Martínez-Salas E; Sobrino F
    J Gen Virol; 2001 Jan; 82(Pt 1):93-101. PubMed ID: 11125162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of various methods of detection of different forms of dengue virus type 2 RNA in cultured cells.
    Liu HS; Lin YL; Chen CC
    Acta Virol; 1997 Dec; 41(6):317-24. PubMed ID: 9607089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.
    Goris N; De Palma A; Toussaint JF; Musch I; Neyts J; De Clercq K
    Antiviral Res; 2007 Mar; 73(3):161-8. PubMed ID: 17055073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.